Characteristics of patients with MCL
| Characteristics . | N = 4049 . |
|---|---|
| Age (median) | 69 (IQR, 62-76) |
| Sex (%) | |
| Male | 2869 (71%) |
| Female | 1180 (29%) |
| Practice type (%) | |
| Academic | 607 (15%) |
| Community | 3442 (85%) |
| Stage (%) | |
| Stage I/II | 303 (7%) |
| Stage III/IV | 2842 (70%) |
| Unknown/not documented | 904 (22%) |
| Disease subtype (%) | |
| Blastoid | 272 (7%) |
| Leukemic | 193 (5%) |
| Pleomorphic | 105 (3%) |
| NOS | 3479 (86%) |
| Deletion 17p or TP53 mutation (%) | |
| Present | 191 (5%) |
| Absent | 1717 (42%) |
| Unknown/not documented | 2141 (53%) |
| Both NGS and FISH testing available | 146 (4%) |
| Deletion 17p | 41 (28%) |
| TP53 mutation | 14 (10%) |
| Deletion 17p and TP53 mutation | 91 (62%) |
| ECOG (%) | |
| 0-2 | 1765 (44%) |
| 3-4 | 235 (6%) |
| Unknown/not documented | 2049 (50%) |
| MIPI grade (%) | |
| Low | 315 (7%) |
| Intermediate | 523 (12%) |
| High | 619 (15%) |
| Unknown | 2592 (64%) |
| Characteristics . | N = 4049 . |
|---|---|
| Age (median) | 69 (IQR, 62-76) |
| Sex (%) | |
| Male | 2869 (71%) |
| Female | 1180 (29%) |
| Practice type (%) | |
| Academic | 607 (15%) |
| Community | 3442 (85%) |
| Stage (%) | |
| Stage I/II | 303 (7%) |
| Stage III/IV | 2842 (70%) |
| Unknown/not documented | 904 (22%) |
| Disease subtype (%) | |
| Blastoid | 272 (7%) |
| Leukemic | 193 (5%) |
| Pleomorphic | 105 (3%) |
| NOS | 3479 (86%) |
| Deletion 17p or TP53 mutation (%) | |
| Present | 191 (5%) |
| Absent | 1717 (42%) |
| Unknown/not documented | 2141 (53%) |
| Both NGS and FISH testing available | 146 (4%) |
| Deletion 17p | 41 (28%) |
| TP53 mutation | 14 (10%) |
| Deletion 17p and TP53 mutation | 91 (62%) |
| ECOG (%) | |
| 0-2 | 1765 (44%) |
| 3-4 | 235 (6%) |
| Unknown/not documented | 2049 (50%) |
| MIPI grade (%) | |
| Low | 315 (7%) |
| Intermediate | 523 (12%) |
| High | 619 (15%) |
| Unknown | 2592 (64%) |